Research Topics
Genomes and GenesSpecies | L J SokollSummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigenLori J Sokoll
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore Maryland 21287, USA
Urology 60:24-30. 2002..Thus, specimen handling should be considered when interpreting PSA results. It is recommended that specimens not analyzed the same day (within 8 hours of collection) be stored frozen at -20 degrees C...
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation studyLori J Sokoll
Departments of Pathology and Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Urol 180:539-43; discussion 543. 2008..This study evaluated the [-2]proenzyme prostate specific antigen serum marker using a blinded reference specimen set from 3 National Cancer Institute Early Detection Research Network centers from men with an indication for prostate biopsy...- Measurement of parathyroid hormone and application of parathyroid hormone in intraoperative monitoringLori J Sokoll
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Clin Lab Med 24:199-216. 2004..The clinical laboratory will continue to play a vital role in providing testing and support for this important mediator of mineral metabolism... - Multicenter analytical performance evaluation of the Elecsys proBNP assayLori J Sokoll
Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Chem Lab Med 42:965-72. 2004..In summary, the Elecsys proBNP assay exhibits good technical performance and is suitable for use in routine clinical laboratories to aid in the diagnosis of congestive heart failure... - A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessLori J Sokoll
Department of Pathology, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Meyer B 125, Baltimore, MD 21287, USA
Cancer Epidemiol Biomarkers Prev 19:1193-200. 2010..The study objective was to characterize the clinical utility of serum [-2]proPSA for prostate cancer detection and assess its association with aggressive disease... - Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 menLori J Sokoll
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
Urology 60:18-23. 2002..985). In summary, cPSA was equivalent to total PSA in predicting organ-confined disease. Present and future models and nomograms using PSA as an indicator of pathological stage could consider use of cPSA... - Intraoperative parathyroid hormone analysis: A study of 200 consecutive casesL J Sokoll
Departments of Pathology and Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Chem 46:1662-8. 2000..The purpose of this study was to evaluate the analytical performance of a rapid PTH assay and its clinical performance in a series of 200 patients... - Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patientsY Wang
Department of Pathology, Johns Hopkins Medical Institutions, 600 N. Wolfe Street/Meyer B-121, Baltimore, MD 21287, USA
Cancer Lett 167:99-104. 2001..39+/-0.35 units/l) compared with healthy subjects (0.27+/-0.02 units/l, P<0.05). Taken together, our data suggest that FAS expression may be a useful tumor marker for breast cancer and play a role in assessing cancer virulence... - Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patientsOmar F Laterza
Department of Pathology, Johns Hopkins University School of Medicine, 600 N Wolfe St Meyer B125, Baltimore, MA 21287, USA
Clin Chim Acta 348:163-9. 2004..Our goal was to determine the ability of circulating concentrations of PAPP-A to predict adverse events in patients presenting to the Emergency Department (ED) with symptoms of ACS... - Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancerFrank H Wians
Department of Pathology, The University of Texas Southwestern Medical Center, 193 Dallas, TX, USA
Clin Chim Acta 326:81-95. 2002..The advantages of EMR over SKR tPSA assays are controversial... - One hundred consecutive minimally invasive parathyroid explorationsR Udelsman
Departments of Surgery and Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
Ann Surg 232:331-9. 2000..To review the outcomes of 100 consecutive minimally invasive parathyroid explorations... - Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancerM Han
Department of Urology, James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Urology 57:707-11. 2001..Proportional hazards modeling using preoperative variables demonstrated that the serum ACP level is an independent predictor of tumor recurrence following RRP... - Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/mlMasood A Khan
James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
J Urol 170:723-6. 2003..CONCLUSIONS: Sum-proPSA, total PSA and %fPSA in combination improve the specificity of early prostate cancer detection in men with a total PSA of 4 to 10 ng/ml compared with the results of individual PSA molecular forms measured... - Unusually high concentrations of cTnI and cTnT in a patient with catastrophic antiphospholipid antibody syndromeOmar F Laterza
Department of Pathology, The Johns Hopkins University School of Medicine, 600 N Wolfe St, Meyer B125, Baltimore, MD 21287, USA
Clin Chim Acta 337:173-6. 2003..The degree of their elevation, in the context of the chronic autoimmune condition of the patient, elicited a thorough investigation for the presence of interfering antibodies... - Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammationKazutoshi Fujita
The Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21224, USA
Prostate 68:872-82. 2008..In order to better understand the relationship between cytokines and prostate cancer, we profiled cytokines in prostatic fluids obtained from cancerous prostate glands and correlated them to both cancer status and inflammatory grade... 
N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overloadAaron A R Tobian
Transfusion Medicine Division and Clinical Chemistry Division, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Transfusion 48:1143-50. 2008..In this study, whether NT-proBNP is a useful diagnostic marker for TACO was evaluated...- Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason gradeAlexander Haese
Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Urol 173:752-6. 2005..Now we evaluated the usefulness of hK2, as measured by 2 entirely different immunoassay designs, to enhance the discrimination of pathologically organ from nonorgan confined clinical stage T1c PCa... - Serum leptin and pathological findings at the time of radical prostatectomyStephen J Freedland
James Buchanan Brady Urological Institute and the Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Urol 173:773-6. 2005..Obese men have higher serum leptin, a hormone produced by adipocytes, which has also been shown to be an in vitro prostate cancer growth factor. We examined whether serum leptin correlates with advanced pathological findings at RP... - Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomyStephen J Freedland
The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 2101, USA
J Urol 174:1266-70. 2005..Obesity has been associated with advanced stage and a higher risk of biochemical progression following radical prostatectomy (RP) in several series. We examined whether serum adiponectin is associated with advanced disease stage at RP... - Assessment of BNP and NT-proBNP in emergency department patients presenting with suspected acute coronary syndromesScott J Cameron
Clinical Chemistry Division, Department of Pathology, Johns Hopkins Medical Institutions, Meyer B 121, 600 N Wolfe Street, Baltimore, MD 21287, USA
Clin Biochem 39:11-8. 2006..The relationship between BNP and NT-proBNP among physiologically and clinically relevant demographic subgroups has never been clarified in the context of the emergency department (ED)... - A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromesScott J Cameron
Department of Pathology, Clinical Chemistry Division, Johns Hopkins Medical Institutions, 600 N Wolfe Street, Baltimore, MD 21287, United States
Clin Chim Acta 376:168-73. 2007..We evaluated the prognostic performance of each of these markers, individually, and in combination in patients presenting to the emergency department (ED) with ACS symptoms... - Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivoSamuel R Denmeade
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA
Prostate 56:45-53. 2003..Recent data also suggest that the PSA protein itself, independent of enzymatic activity, may also function as an endothelial cell-specific inhibitor of angiogenesis... - Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patternsDanni L Meany
Department of Pathology, Johns Hopkins University, Baltimore, Maryland 21231, USA
J Proteome Res 8:613-9. 2009..71) appeared to perform better than percent free PSA (AUC = 0.54) in its diagnostic gray zone between 10 and 20% in a subset of 21 subjects. A separate study of 16 additional subjects showed similar findings... - Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang
Department of Pathology, Biomarker Discovery Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
Cancer Res 64:5882-90. 2004..These biomarkers demonstrated the potential to improve the detection of early stage ovarian cancer... - Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer modelsSamuel R Denmeade
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA
Prostate 54:249-57. 2003..regulation of expression of prostate differentiation specific markers PSA, hK2, and PSMA... - Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Urology 61:274-6. 2003..A large prospective clinical trial is needed to confirm these preliminary findings... - Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomyJ Kellogg Parsons
James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institution, Baltimore, MD, USA
BJU Int 99:758-61. 2007..To determine the validity of using complexed prostate-specific antigen (cPSA) levels for diagnosing biochemical recurrence after radical prostatectomy (RP)... - Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systemsAlexander Haese
The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Clin Chem 48:944-7. 2002 - Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancerHsueh-Wei Chang
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
J Natl Cancer Inst 94:1697-703. 2002..AI was detected with high specificity in plasma DNA from patients with ovarian cancer and should be studied further as a screening tool... - Standardization of two immunoassays for human glandular kallikrein 2Alexander Haese
Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University Medical Institutions, Baltimore, MD 21287, USA
Clin Chem 49:601-10. 2003..We compared two hK2 assays and five different recombinant hK2 variants (rhK2) and suggest a common calibrator as an important step and putative reference substance in hK2 assay standardization... - Proteomic approaches to tumor marker discoveryAlex J Rai
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Arch Pathol Lab Med 126:1518-26. 2002..Additional studies are required to further validate these biomarkers... - Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassayJin Song
Center for Biomarker Discovery, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
Clin Chem 52:1045-53. 2006..These fragmentation patterns could be useful as potential biomarkers for detection and classification of cancer... - Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markersEddy S Leman
The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Cancer Res 67:5600-5. 2007..ROC curves for CCSA-3 and CCSA-4 reveal an area under the curve of 0.94 (95% CI, 0.90-0.98%). In these initial analyses, CCSA-3 and CCSA-4 show promise as potential serum markers for detection of colorectal cancer and advanced adenomas... - Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkersC Nicole Rosenzweig
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Urol 181:1407-14. 2009..We hypothesized that biomarkers are present in preoperative serum, which may be used to predict the probability of biochemical recurrence following radical prostatectomy... - Bone to total alkaline phosphatase ratios improve sensitivity and specificity of bone alkaline phosphatase immunoassaysL J Sokoll
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Biochem 30:625-9. 1997..Evaluate the ability of two bone alkaline phosphatase (ALPB) immunoassays (Ostase, Hybritech Inc and Alkphase-B, Metra Biosystems) to clinically differentiate between osseous and non-osseous ALP sources... - Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancerEddy S Leman
The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
Clin Cancer Res 14:1349-54. 2008..CCSA-2 is a distinct novel colon cancer marker identified using focused proteomics... - Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance programJeffrey J Tosoian
Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
J Urol 183:534-8. 2010..We assessed the relationship between PCA3 and prostate biopsy results in men in a surveillance program... - A new model ELISA, based on two monoclonal antibodies, for quantification of fatty acid synthaseYoung Y Wang
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
J Immunoassay Immunochem 23:279-92. 2002..In summary, this monoclonal-monoclonal FAS-ELISA is sensitive, accurate, and precise in quantification of fatty acid synthase and has potential as a complementary tool in testing clinical samples... - Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft modelsS R Denmeade
The Johns Hopkins Oncology Center, Bunting Blaustein Cancer Research Building, Baltimore, Maryland 21231, USA
Prostate 48:1-6. 2001..Prostate-specific antigen (PSA) targeted prodrugs are under development in our laboratory. Concentrations of total PSA and enzymatically active PSA produced by various human prostate cancer xenograft models have not been well characterized... - Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1R D Semba
Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
J Infect Dis 180:93-8. 1999..0001). Mastitis and breast milk HIV-1 load may increase the risk of vertical transmission of HIV-1 through breast-feeding... - EPCA-2: a highly specific serum marker for prostate cancerEddy S Leman
Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
Urology 69:714-20. 2007..To describe the initial assessment of early prostate cancer antigen (EPCA)-2 as a serum marker for the detection of prostate cancer and to examine its sensitivity and specificity... - Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancersJens Koopmann
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
Clin Cancer Res 10:2386-92. 2004..In this study, we evaluated serum macrophage inhibitory cytokine-1 (MIC-1) as a marker of pancreatic cancer... - A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracyLori J Sokoll
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Chim Acta 389:1-6. 2008..Measurement of prostate cancer gene 3 (PCA3) mRNA normalized to prostate-specific antigen (PSA) mRNA in urine has been proposed as a marker for prostate cancer... - Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cellsSusan Dalrymple
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Departments of Urology and Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21231-1000, USA
Cancer Res 65:9269-79. 2005..These characteristic changes are consistent with prostate cancer cells' ability to metastasize to bone, a site of high-Ca2+ levels... - Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan
Department of Urology, James Buchanan Brady Urological Institute and the Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 21287-2101, USA
Urology 64:1160-4. 2004.... - Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testingLori J Sokoll
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Chem 50:1126-35. 2004..CONCLUSION: The emergence of these rapid intraoperative immunoassays indicates that this test format is likely to provide future opportunities to improve patient care by advances in clinical laboratory testing... - Comparison of total prostate-specific antigen and derivative levels in a screening population of black, white, and Korean-American menJae Park
James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Marburg 409, 600 North Wolfe Street, Baltimore, MD 21287, USA
Clin Prostate Cancer 2:173-6. 2003..In a contemporary screening population comparing tPSA, percentage of fPSA, and percentage of cPSA levels in 3 races, there were no significant differences identified among the groups... - Increased plasma DNA integrity in cancer patientsBrant G Wang
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
Cancer Res 63:3966-8. 2003..59. Our findings suggest that increased DNA integrity in plasma DNA is associated with cancer, and measurement of DNA integrity may provide a simple and inexpensive measure for cancer detection... - Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, HemospanScott J Cameron
Department of Pathology, Clinical Chemistry Division, Johns Hopkins Medical Institutions, Meyer B 125 600 N Wolfe Street, Baltimore, MD 21287, USA
Clin Biochem 42:221-4. 2009..To evaluate interference by the hemoglobin-based oxygen carrier Hemospan on clinical laboratory assays... - Retroperitoneal masses with associated human chorionic gonadotropin production: Report of two casesAmy S Duffield
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Chim Acta 395:166-9. 2008..The production of human chorionic gonadotropin (hCG) can be stimulated by both pregnancy and malignancy... - Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentrationSiobhan Sutcliffe
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
J Urol 175:1937-42. 2006..Further studies are warranted to replicate study findings and determine host and infection characteristics associated with large PSA increases... - Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancerYoung Y Wang
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
J Exp Ther Oncol 4:101-10. 2004..In comparison with CA27.29, no correlation between these two tumor markers was found. Thus, the extracellular FAS may serve as a potential diagnostic and prognostic marker... - Dysprealbuminemic hyperthyroxinemia in a patient with hyperthyroid graves diseaseScott J Cameron
Clinical Chemistry Division, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287 0003, USA
Clin Chem 51:1065-9. 2005..These findings indicate that hypothyroidism can be masked by coexisting euthyroid dysprealbuminemic hyperthyroxinemia... - Analytical performance of 4 automated assays for measurement of cystatin CJinong Li
Division of Clinical Chemistry, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Chem 56:1336-9. 2010.... - Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancerKoji Okihara
University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA
J Urol 167:2017-23; discussion 2023-4. 2002..Percent free PSA outperforms complexed PSA and percent complexed PSA performed equivalently to percent free PSA in all total PSA ranges analyzed between 2.5 and 10 ng./ml... - Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibilityO John Semmes
Department of Microbiology and Molecular Cell Biology, Virginia Prostate Center, Eastern Virginia Medical School, Norfolk, VA 23507, USA
Clin Chem 51:102-12. 2005..This report describes the first stage of a National Cancer Institute/Early Detection Research Network-sponsored multiinstitutional evaluation and validation of this approach for detection of prostate cancer... - Total, free and complexed PSA and hK2 for early detection of prostate cancerAlexander Haese
University Clinic Eppendorf, Hamburg, Germany
MLO Med Lab Obs 35:14-6, 20, 22 passim; quiz 30-1. 2003 - Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancerYoshio Naya
Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston 77030-4095, USA
Urology 62:1058-62. 2003..001; diagnostic accuracy P <0.05). CONCLUSIONS: In men with nonpalpable prostate cancer, the density parameters of tPSA, cPSA, and fPSA performed equivalently and appeared to enhance the predictability of EPE... - Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Yoshio Naya
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4095, USA
Urology 60:36-41. 2002..05). In the 109 men with a total prostate volume of <30 cm(3), at 90% sensitivity the specificity of cPSA and cPSAD was better than that of percent fPSA. In conclusion, volume-based cPSA can modestly enhance the performance of cPSA... - Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger
Department of Urology, University of Innsbruck, Austria
Urology 60:31-5. 2002..The use of cPSA as a single test was found to enhance detection of prostate cancer over that of testing with tPSA and PSA ratios in men with tPSA values in the range of 2 to 4 ng/mL... - Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosisSamir S Taneja
Department of Urology, New York University School of Medicice, NY, USA
Urology 60:10-7. 2002..Therefore, cPSA could be applied as an accurate predictor of ECE independently or in a nomogram along with other predictive variables... - Rapid parathyroid hormone analysis during venous localizationRobert Udelsman
Department of Surgery, Yale University School of Medicine, Yale New Haven Hospital, 330 Cedar Street, New Haven, CT 06520 8062, USA
Ann Surg 237:714-9; discussion 719-21. 2003..To determine the usefulness of the rapid parathyroid hormone (PTH) assay during venous localization for primary hyperparathyroidism (1 degrees HPTH)... - Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patientsPetra Stieber
Klinikum der Universitat Munchen Grosshadern, Institut fur Klinische Chemie, Munich, Germany
Clin Lab 49:15-24. 2003..The findings indicate that the Elecsys CA 15-3 assay is very suitable in routine work for detection of recurrences as well as for therapy control in metastatic breast cancer...